Viewing Study NCT01797120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-04-25 @ 11:24 PM
Study NCT ID: NCT01797120
Status: COMPLETED
Last Update Posted: 2018-05-30
First Post: 2013-02-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Sponsor: PrECOG, LLC.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Post-Menopausal Patients View
None Hormone-Receptor Positive View
None Resistant to Aromatase Inhibitor Therapy View
None Fulvestrant View
None Faslodex View
None mTOR Inhibitor View
None Everolimus View
None RAD001 View
None Afinitor View